Hi Shaun,
We have not as yet seen any residents receiving or coming into our facility on
this new entity.
Looks crazy expensive $750,000 for first year of therapy and $375,000 for
subsequent years.
Renee
[cid:image001.jpg@01D1CD78.6AB32530]<http://jewishhome.org/>
Renee Hofman B.S ,M.S, Rph.
Director of Pharmacy Services
Sarah Neuman Center
845 Palmer Avenue, Mamaroneck, NY 10543
T 914-864-5190
F 914-864-5195
jewishhome.org
[cid:image002.png@01D1CD78.6AB32530]<https://mobile.twitter.com/newjewishhome>[cid:image003.png@01D1CD78.6AB32530]<https://www.facebook.com/thenewjewishhome/?ref=hl>[cid:image004.png@01D1CD78.6AB32530]<https://www.linkedin.com/company/thenewjewishhome>[cid:image005.png@01D1CD78.6AB32530]<https://vimeo.com/jewishhome>
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Shaun Flynn
Sent: Friday, March 10, 2017 3:16 PM
To: nyschp.dop@xxxxxxxxxxxxx
Subject: [nyschp.dop] Spinraza
Good evening everyone,
The Healthcare Association of New York State (HANYS) has reached out to the
Council to see if our members have experienced any issues with the cost of
Spinraza in their facilities. They are trying to collect some anecdotal
information on the scope and the impact of the issue. Thank you for your
assistance.
Shaun
Shaun Flynn
Executive Director
New York State Council of Health-system Pharmacists
518-456-8819
www.nyschp.org<http://www.nyschp.org/>
[cid:image002.jpg@01D2719B.023D7F60]
Confidentiality Notice: The information contained in this e-mail is legally
privileged and confidential. This information is intended for the sole use of
the individual(s) or entity named in the message header. If you are not the
intended recipient, you are hereby notified that any dissemination, copying or
action taken in reliance on the contents of this information is strictly
prohibited. If you receive this message in error, please notify the sender and
delete this message in it's entirely
The information in this e-mail may be confidential or contain information
protected by Federal and State Privacy laws. If you are not the intended
recipient, any review or dissemination of the information contained in this
message is prohibited by law. If you have received this e-mail in error, please
notify the sender and delete this e-mail. Thank you.